Mechanisms of Hepatocyte Organic Anion Transport

Physiology of the Gastrointestinal Tract

Volumn 2, Issue , 2012, Pages 1485-1506

  Wolkoff, Allan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882501423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382026-6.00054-3     Document Type: Chapter

References (313)

1. Gartner U, Stockert RJ, Levine WG, Wolkoff AW Effect of nafenopin on the uptake of bilirubin and sulfobromophthalein by isolated perfused rat liver. Gastroenterology 1982, 83:1163-1169.
2. Stollman YR, Gartner U, Theilmann L, Ohmi N, Wolkoff AW Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding. J Clin Invest 1983, 72:718-723.
3. Gartner U, Goeser T, Wolkoff AW Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 1997, 113:1707-1713.
4. Wolkoff AW The role of an albumin receptor in hepatic organic anion uptake: the controversy continues. Hepatology 1987, 7:777-779.
5. - on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest 1987, 79:1259-1268.
6. Min AD, Johansen KJ, Campbell CG, Wolkoff AW Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter. J Clin Invest 1991, 87:1496-1502.
7. Inoue M, Hirata E, Morino Y, Nagase S, Chowdhury JR, Chowdhury NR, et al. The role of albumin in the hepatic transport of bilirubin: studies in mutant analbuminemic rats. J Biochem 1985, 97:737-743.
8. Schwenk M, Burr R, Schwarz L, Pfaff E Uptake of bromosulfophthalein by isolated liver cells. Eur J Biochem 1976, 64:189-197.
9. Van Bezooijen CFA, Grell T, Knook DL Bromsulfophthalein uptake by isolated liver parenchymal cells. Biochem Biophys Res Commun 1976, 69:354-361.
10. Schwarz LR, Gotz R, Klaassen CD Uptake of sulfobromophthalein-glutathione conjugate by isolated hepatocytes. Am J Physiol 1980, 239:C118-C123.
11. Wang P, Kim RB, Chowdhury JR, Wolkoff AW The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem 2003, 278:20695-20699.
12. Min AD, Goeser T, Liu R, Campbell CG, Novikoff PM, Wolkoff AW Organic anion transport in HepG2 cells: absence of the high-affinity, chloride-dependent transporter. Hepatology 1991, 14:1217-1223.
13. Wolkoff AW Hepatocellular sinusoidal membrane organic anion transport and transporters. Semin Liver Dis 1996, 16:121-127.
14. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopus laevis oocytes. J Clin Invest 1991, 88:2146-2149.
15. Gartner U, Stockert RJ, Morell AG, Wolkoff AW Modulation of the transport of bilirubin and asialoorosomucoid during liver regeneration. Hepatology 1981, 1:99-106.
16. 4- modulates organic anion transport by rat hepatocytes. J Biol Chem 1993, 268:15399-15404.
17. Glavy JS, Wu SM, Wang PJ, Orr GA, Wolkoff AW Down-regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of oatp1. J Biol Chem 2000, 275:1479-1484.
18. Reichen J, Berk PD Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun 1979, 91:484-489.
19. Reichen J, Blitzer BL, Berk PD Binding of unconjugated and conjugated sulfobromophthalein to rat liver plasma membrane fractions in vitro. Biochim Biophys Acta 1981, 640:298-312.
20. Stremmel W, Gerber MA, Glezerov V, Thung SN, Kochwa S, Berk PD Physicochemical and immunohistological studies of a sulfobromophthalein-and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest 1983, 71:1796-1805.
21. Lunazzi G, Tiribelli C, Gazzin B, Sottocasa G Further studies on bilitranslocase, a plasma membrane protein involved in hepatic organic anion uptake. Biochim Biophys Acta 1982, 685:117-122.
22. Stremmel W, Diede HE Cellular uptake of conjugate bilirubin and sulfobromophthalein (BSP) by the human hepatoma cell line Hep G2 is mediated by a membrane BSP/bilirubin binding protein. J Hepatol 1990, 10:99-104.
23. Tiribelli C, Lunazzi GC, Sottocasa GL Biochemical and molecular aspects of the hepatic uptake of organic anions. Biochim Biophys Acta 1990, 1031:261-275.
24. Sottocasa GL, Baldini G, Sandri G, Lunazzi G, Tiribelli C Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase. Biochim Biophys Acta 1982, 685:123-128.
25. Sottocasa GL, Passamonti S, Battiston L, Pascolo L, Tiribelli C Molecular aspects of organic anion uptake in liver. J Hepatol 1996, 24:36-41.
26. Miccio M, Baldini G, Basso V, Grazzin B, Lunazzi GC, Tiribelli C, et al. Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromophthalein in plasma membrane vesicles from rat liver: immunochemical evidence using mono-and poly-clonal antibodies. Biochim Biophys Acta 1989, 981:115-120.
27. Passamonti S, Vrhovsek U, Vanzo A, Mattivi F The stomach as a site for anthocyanins absorption from food. FEBS Lett 2003, 544:210-213.
28. Marchegiano P, Carubbi F, Tiribelli C, Amarri S, Stebel M, Lunazzi GC, et al. Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. Biochem Biophys Res Commun 1992, 183:1203-1208.
29. Maestro A, Terdoslavich M, Vanzo A, Kuku A, Tramer F, Nicolin V, et al. Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc Res 2010, 85:175-183.
30. Battiston L, Passamonti S, Macagno A, Sottocasa GL The bilirubin-binding motif of bilitranslocase and its relation to conserved motifs in ancient biliproteins. Biochem Biophys Res Commun 1998, 247:687-692.
31. Battiston L, Macagno A, Passamonti S, Micali F, Sottocasa GL Specific sequence-directed anti-bilitranslocase antibodies as a tool to detect potentially bilirubin-binding proteins in different tissues of the rat. FEBS Lett 1999, 453:351-355.
32. Wolkoff AW, Chung CT Identification, purification, and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest 1980, 65:1152-1161.
33. Goeser T, Nakata R, Braly LF, Sosiak A, Campbell CG, Dermietzel R, et al. The rat hepatocyte plasma membrane organic anion binding protein is immunologically related to the mitochondrial F1 adenosine triphosphatase beta-subunit. J Clin Invest 1990, 86:220-227.
34. +-independent organic anion transporter. Proc Natl Acad Sci USA 1994, 91:133-137.
35. Hagenbuch B, Meier PJ Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 2004, 447:653-665.
36. Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier PJ, Stieger B Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol 2009, 296:C570-C582.
37. Hagenbuch B, Meier PJ The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003, 1609:1-18.
38. Klaassen CD, Aleksunes LM Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010, 62:1-96.
39. Shi X, Bai S, Ford AC, Burk RD, Jacquemin E, Hagenbuch B, et al. Stable inducible expression of a functional rat liver organic anion transport protein in HeLa Cells. J Biol Chem 1995, 270:25591-25595.
40. - exchange. J Biol Chem 1997, 272:26340-26345.
41. Eckhardt U, Horz JA, Petzinger E, Stuber W, Reers M, Dickneite G, et al. The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide. Hepatology 1998, 24:380-384.
42. Pang KS, Wang PJ, Chung AY, Wolkoff AW The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein. Hepatology 1998, 28:1341-1346.
43. Kanai N, Lu R, Bao Y, Wolkoff AW, Vore M, Schuster VL Estradiol 17b-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. Am J Physiol 1996, 270:F326-F331.
44. Bossuyt X, Muller M, Hagenbuch B, Meier PJ Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J Pharm Exper Ther 1996, 276:891-896.
45. Chang C, Pang KS, Swaan PW, Ekins S Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1. J Pharmacol Exp Ther 2005, 314:533-541.
46. Wang P, Hata S, Xiao Y, Murray JW, Wolkoff AW Topological assessment of oatp1a1: a 12 transmembrane domain integral membrane protein with three N-linked carbohydrate chains. Am J Physiol Gastrointest Liver Physiol 2008.
47. Angeletti RH, Novikoff PM, Juvvadi S, Fritschy J-M, Meier PJ, Wolkoff AW The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc Natl Acad Sci USA 1997, 94:283-286.
48. Angeletti RH, Bergwerk AJ, Novikoff PM, Wolkoff AW Dichotomous development of the organic anion transport protein in liver and choroid plexus. Am J Physiol 1998, 275:C882-C887.
49. Bergwerk AJ, Shi X, Ford AC, Kanai N, Jacquemin E, Burk RD, et al. Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol 1996, 271:G231-G238.
50. Yang CH, Glover KP, Han X Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats. Toxicol Lett 2009, 190:163-171.
51. Cheng X, Maher J, Chen C, Klaassen CD Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab Dispos 2005, 33:1062-1073.
52. Zaher H, zu Schwabedissen HE, Tirona RG, Cox ML, Obert LA, Agrawal N, et al. Targeted disruption of murine organic anion-transporting polypeptide 1b2 (oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin. Mol Pharmacol 2008, 74:320-329.
53. Corpet F Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988, 16:10881-10890.
54. Wang P, Wang JJ, Xiao Y, Murray JW, Novikoff PM, Angeletti RH, et al. Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 (OATP1A1) on the hepatocyte surface. J Biol Chem 2005, 280:30143-30149.
55. Liu L, Mak E, Tirona RG, Tan E, Novikoff PM, Wang P, et al. Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver. J Pharmacol Exp Ther 2005, 315:433-448.
56. Lee TK, Koh AS, Cui Z, Pierce RH, Ballatori N N-glycosylation controls functional activity of Oatp1, an organic anion transporter. Am J Physiol Gastrointest Liver Physiol 2003, 285:G371-G381.
57. Kullak-Ublick G-A, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 1994, 20:411-416.
58. Kontaxi M, Eckhardt U, Hagenbuch B, Stieger B, Meier PJ, Petzinger E Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. J Pharm Exper Ther 1996, 279:1507-1513.
59. Lu R, Kanai N, Bao Y, Wolkoff AW, Schuster VL Regulation of renal oatp mRNA expression by testosterone. Am J Physiol 1996, 270:F332-F337.
60. Kanai N, Lu R, Bao Y, Wolkoff AW, Schuster VL Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates. Am J Physiol 1996, 270:F319-F325.
61. Chen C, Stock JL, Liu X, Shi J, Van Deusen JW, Dimattia DA, et al. Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds. Drug Metab Dispos 2008, 36:1840-1845.
62. Lu H, Choudhuri S, Ogura K, Csanaky IL, Lei X, Cheng X, et al. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR. Toxicol Sci 2008, 103:35-45.
63. Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. SLCO1B1 variants and statin-induced myopathy-a genomewide study. N Engl J Med 2008, 359:789-799.
64. Ho RH, Choi L, Lee W, Mayo G, Schwarz UI, Tirona RG, et al. Effect of drug transporter genotypes on pravastatin disposition in European-and African-American participants. Pharmacogenet Genomics 2007, 17:647-656.
65. Choi JH, Lee MG, Cho JY, Lee JE, Kim KH, Park K Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. Clin Pharmacol Ther 2008, 83:251-257.
66. Ieiri I, Suwannakul S, Maeda K, Uchimaru H, Hashimoto K, Kimura M, et al. SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers. Clin Pharmacol Ther 2007, 82:541-547.
67. Zhang W, Chen BL, Ozdemir V, He YJ, Zhou G, Peng DD, et al. SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. Br J Clin Pharmacol 2007, 64:346-352.
68. Kivisto KT, Niemi M Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans. Pharm Res 2007, 24:239-247.
69. van de SE, Wagenaar E, van der Kruijssen CM, Burggraaff JE, de Waart DR, Elferink RP, et al. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest 2010, 120:2942-2952.
70. Guo GL, Klaassen CD Protein kinase C suppresses rat organic anion transporting polypeptide 1-and 2-mediated uptake. J Pharmacol Exp Ther 2001, 299:551-557.
71. Xiao Y, Nieves E, Angeletti RH, Orr GA, Wolkoff AW Rat organic anion transporting protein 1A1 (Oatp1a1): purification and phosphopeptide assignment. Biochem 2006, 45:3357-3369.
72. Gao B, St.Pierre MV, Stieger B, Meier PJ Differential expression of bile salt and organic anion transporters in developing rat liver. J Hepatol 2004, 41:201-208.
73. +-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J Biol Chem 2004, 279:7213-7222.
74. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff AW, Sutherland E Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996, 271:G1043-G1052.
75. Geier A, Dietrich CG, Gerloff T, Haendly J, Kullak-Ublick GA, Stieger B, et al. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim Biophys Acta 2003, 1609:87-94.
76. Lund M, Kang L, Tygstrup N, Wolkoff AW, Ott P Effects of LPS on transport of indocyanine green and alanine uptake in perfused rat liver. Am J Physiol 1999, 277:G91-G100.
77. Trauner M, Meier PJ, Boyer JL Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol 1999, 31:165-178.
78. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 1997, 27:1051-1056.
79. Simon FR, Fortune J, Iwahashi M, Bowman S, Wolkoff A, Sutherland E Characterization of the mechanisms involved in the gender differences in hepatic taurocholate uptake. Am J Physiol 1999, 276:G556-G565.
80. Cao J, Stieger B, Meier PJ, Vore M Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 2002, 283:G757-G766.
81. Cao J, Huang L, Liu Y, Hoffman T, Stieger B, Meier PJ, et al. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology 2001, 33:140-147.
82. Gerloff T, Geier A, Stieger B, Hagenbuch B, Meier PJ, Matern S, et al. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology 1999, 117:1408-1415.
83. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
84. Trauner M, Boyer JL Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003, 83:633-671.
85. Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, et al. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 2001, 27:375-382.
86. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001, 21:1393-1403.
87. Kullak-Ublick GA, Stieger B, Meier PJ Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004, 126:322-342.
88. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001, 98:3369-3374.
89. Guo GL, Staudinger J, Ogura K, Klaassen CD Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. Mol Pharmacol 2002, 61:832-839.
90. Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J Biol Chem 2001, 276:37206-37214.
91. Rausch-Derra LC, Hartley DP, Meier PJ, Klaassen CD Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2. Hepatology 2001, 33:1469-1478.
92. Hagenbuch N, Reichel C, Stieger B, Cattori V, Fattinger KE, Landmann L, et al. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol 2001, 34:881-887.
93. Tirona RG, Leake BF, Wolkoff AW, Kim RB Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 2003, 304:223-228.
94. Hata S, Wang P, Eftychiou N, Ananthanarayanan M, Batta A, Salen G, et al. Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am J Physiol Gastrointest Liver Physiol 2003, 285:G829-G839.
95. Hagenbuch B, Gui C Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008, 38:778-801.
96. van Montfoort JE, Hagenbuch B, Fattinger KE, Müller M, Groothuis GMM, Meijer DKF, et al. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations. J Pharm Exper Ther 1999, 291:147-152.
97. Wolkoff AW, Goresky CA, Sellin J, Gatmaitan Z, Arias IM Role of ligandin in transfer of bilirubin from plasma into liver. Am J Physiol 1979, 236:E638-E648.
98. Scharschmidt BF, Waggoner JG, Berk PD Hepatic organic anion uptake in the rat. J Clin Invest 1975, 56:1280-1292.
99. Bloomer JR, Zaccaria J Effect of graded bilirubin loads on bilirubin transport by perfused rat liver. Am J Physiol 1976, 230:736-742.
100. Briz O, Serrano MA, Macias RI, Gonzalez-Gallego J, Marin JJ Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J 2003, 371:897-905.
101. Cui Y, Konig J, Leier I, Buchholz U, Keppler D Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001, 276:9626-9630.
102. Zucker SD, Goessling W, Hoppin AG Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999, 274:10852-10862.
103. Zucker SD, Goessling W Mechanism of hepatocellular uptake of albumin-bound bilirubin. Biochim Biophys Acta 2000, 1463:197-208.
104. Roda A, Cappelleri G, Aldini R, Roda E, Barbara L Quantitative aspects of the interaction of bile acids with human serum albumin. J Lipid Res 1982, 23:490-495.
105. Salvioli G, Lugli R, Pradelli JM, Gigliotti G Bile acid binding in plasma: the importance of lipoproteins. FEBS Lett 1985, 187:272-276.
106. Reichen J, Paumgartner G Uptake of bile acids by perfused rat liver. Am J Physiol 1976, 231:734-742.
107. Schwarz LR, Burr R, Schwenk M, Pfaff E, Greim H Uptake of taurocholic acid into isolated rat-liver cells. Eur J Biochem 1975, 55:617-623.
108. Van Dyke RW, Stephens JE, Scharschmidt BF Bile acid transport in cultured rat hepatocytes. Am J Physiol 1982, 243:G484-G492.
109. Dietmaier A, Gasser R, Graf J, Peterlik M Investigations on the sodium dependence of bile acid fluxes in the isolated perfused rat liver. Biochim Biophys Acta 1976, 443:81-91.
110. Inoue M, Kinne R, Tran T, Arias IM Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport. Hepatology 1982, 2:572-579.
111. Ruifrok PG, Meijer DK Sodium ion-coupled uptake of taurocholate by rat-liver plasma membrane vesicles. Liver 1982, 2:28-34.
112. Duffy MC, Blitzer BL, Boyer JL Direct determination of the driving forces for taurocholate uptake into rat liver plasma membrane vesicles. J Clin Invest 1983, 72:1470-1481.
113. Blitzer BL, Donovan CB A new method for the rapid isolation of basolateral plasma membrane vesicles from rat liver. Characterization, validation, and bile acid transport studies. J Biol Chem 1984, 259:9295-9301.
114. Meier PJ, Meier-Abt A, Barrett C, Boyer JL Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier. J Biol Chem 1984, 259:10614-10622.
115. Simion FA, Fleischer B, Fleischer S Ionic requirements for taurocholate transport in rat liver plasma membrane vesicles. J Bioenerg Biomembr 1984, 16:507-515.
116. Lidofsky SD, Fitz JG, Weisiger RA, Scharschmidt BF Hepatic taurocholate uptake is electrogenic and influenced by transmembrane potential difference. Am J Physiol 1993, 264:G478-G485.
117. von Dippe P, Levy D Characterization of the bile acid transport system in normal and transformed hepatocytes. Photoaffinity labeling of the taurocholate carrier protein. J Biol Chem 1983, 258:8896-8901.
118. Wieland T, Nassal M, Kramer W, Fricker G, Bickel U, Kurz G Identity of hepatic membrane transport systems for bile salts, phalloidin, and antamanide by photoaffinity labeling. Proc Natl Acad Sci USA 1984, 81:5232-5236.
119. Elsner R, Ziegler K Determination of the apparent functional molecular mass of the hepatocellular sodium-dependent taurocholate transporter by radiation inactivation. Biochim Biophys Acta 1989, 983:113-117.
120. Elsner RH, Ziegler K Radiation inactivation of multispecific transport systems for bile acids and xenobiotics in basolateral rat liver plasma membrane vesicles. J Biol Chem 1992, 267:9788-9793.
121. +/bile acid cotransport system. Proc Natl Acad Sci USA 1991, 88:10629-10633.
122. Meier PJ Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol 1995, 269:G801-G812.
123. +/taurocholate cotransporting polypeptide (ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells. J Pharm Exper Ther 2000, 292:505-511.
124. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997, 26:1667-1677.
125. +-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. Am J Physiol 1998, 274:G370-G375.
126. Baringhaus KH, Matter H, Stengelin S, Kramer W Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na( + )/bile acid cotransporter. J Lipid Res 1999, 40:2158-2168.
127. Kramer W, Stengelin S, Baringhaus KH, Enhsen A, Heuer H, Becker W, et al. Substrate specificity of the ileal and the hepatic Na( + )/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters. J Lipid Res 1999, 40:1604-1617.
128. Hardikar W, Ananthanarayanan M, Suchy FJ Differential ontogenic regulation of basolateral and canalicular bile acid transport proteins in rat liver. J Biol Chem 1995, 270:20841-20846.
129. + -bile acid cotransporter using peptide and fusion protein antibodies. Am J Physiol 1994, 267:G637-G643.
130. Meier PJ, Stieger B Bile salt transporters. Annu Rev Physiol 2002, 64:635-661.
131. Kosters A, Karpen SJ Bile acid transporters in health and disease. Xenobiotica 2008, 38:1043-1071.
132. Hagenbuch B, Scharschmidt BF, Meier PJ Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem J 1996, 316:901-904.
133. Wolkoff AW, Cohen DE Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids. Am J Physiol Gastrointest Liver Physiol 2003, 284:G175-G179.
134. Gordon N, Newton RW Glucose transporter type1 (GLUT-1) deficiency. Brain Dev 2003, 25:477-480.
135. De Vivo DC, Wang D, Pascual JM, Ho YY Glucose transporter protein syndromes. Int Rev Neurobiol 2002, 51:259-288.
136. Martin MG, Lostao MP, Turk E, Lam J, Kreman M, Wright EM Compound missense mutations in the sodium/D-glucose cotransporter result in trafficking defects. Gastroenterology 1997, 112:1206-1212.
137. Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, et al. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 2003, 278:33920-33927.
138. Oelkers P, Kirby LC, Heubi JE, Dawson PA Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 1997, 99:1880-1887.
139. Wong MH, Oelkers P, Dawson PA Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J Biol Chem 1995, 270:27228-27234.
140. De LV, Ginter CS, Carrasco N The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number. J Cell Sci 2004, 117:677-687.
141. Pascual JM, Wang D, Lecumberri B, Yang H, Mao X, Yang R, et al. GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol 2004, 150:627-633.
142. Fujiwara H, Tatsumi K, Tanaka S, Kimura M, Nose O, Amino N A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect. Thyroid 2000, 10:471-474.
143. Meerman L, Koopen NR, Bloks V, van Goor H, Havinga R, Wolthers BG, et al. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology 1999, 117:696-705.
144. +/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996, 110:199-209.
145. von Dippe P, Amoui M, Stellwagen RH, Levy D The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase. J Biol Chem 1996, 271:18176-18180.
146. von Dippe P, Levy D Reconstitution of the immunopurified 49-kDa sodium-dependent bile acid transport protein derived from hepatocyte sinusoidal plasma membranes. J Biol Chem 1990, 265:14812-14816.
147. Zhu Q, von Dippe P, Xing W, Levy D Membrane topology and cell surface targeting of microsomal epoxide hydrolase. Evidence for multiple topological orientations. J Biol Chem 1999, 274:27898-27904.
148. Honscha W, Platte HD, Oesch F, Friedberg T Relationship between the microsomal epoxide hydrolase and the hepatocellular transport of bile acids and xenobiotics. Biochem J 1995, 311:975-979.
149. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Fernandez-Salguero P, et al. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem 1999, 274:23963-23968.
150. Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B, et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 2003, 369:539-547.
151. White IR, Man WJ, Bryant D, Bugelski P, Camilleri P, Cutler P, et al. Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands. Proteomics 2003, 3:505-512.
152. +-dependent taurocholate transport site in isolated rat hepatocytes. Am J Physiol 1984, 246:G477-G483.
153. +-dependent taurocholate transporter: influence of side chain length and charge. Hepatology 1991, 13:68-72.
154. Han YH, Busler D, Hong Y, Tian Y, Chen C, Rodrigues AD Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters. Drug Metab Dispos 2010, 38:1072-1082.
155. Smith DJ, Grossbard M, Gordon ER, Boyer JL Taurocholate uptake by isolated skate hepatocytes: effect of albumin. Am J Physiol 1987, 252:G479-G484.
156. Jacquemin E, Hagenbuch B, Wolkoff AW, Meier PJ, Boyer JL Expression of sodium-independent organic anion uptake systems of skate liver in Xenopus laevis oocytes. Am J Physiol 1995, 268:G18-G23.
157. Cai SY, Wang W, Soroka CJ, Ballatori N, Boyer JL An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins. Am J Physiol Gastrointest Liver Physiol 2002, 282:G702-G710.
158. Seward DJ, Koh AS, Boyer JL, Ballatori N Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem 2003, 278:27473-27482.
159. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, et al. The heteromeric organic solute transporter alpha-beta, Ostalpha -Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 2004.
160. Rao A, Haywood J, Craddock AL, Belinsky MG, Kruh GD, Dawson PA The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci USA 2008, 105:3891-3896.
161. Soroka CJ, Ballatori N, Boyer JL Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis. Semin Liver Dis 2010, 30:178-185.
162. Soroka CJ, Mennone A, Hagey LR, Ballatori N, Boyer JL Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis. Hepatology 2010, 51:181-190.
163. Suchy FJ, Courchene SM, Blitzer BL Taurocholate transport by basolateral plasma membrane vesicles isolated from developing rat liver. Am J Physiol 1985, 248:G648-G654.
164. +-ATPase activity in fetal and neonatal rat liver plasma membrane vesicles. Am J Physiol 1986, 251:G665-G673.
165. Green RM, Gollan JL, Hagenbuch B, Meier PJ, Beier DR Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol 1997, 273:G621-G627.
166. +/taurocholate cotransport by cyclic AMP. J Biol Chem 1993, 268:17734-17741.
167. Anwer MS Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology 2004, 39:581-590.
168. +-taurocholate cotransport by translocating transporter to plasma membranes. Am J Physiol 1997, 273:G842-G848.
169. Mukhopadhyay S, Ananthanarayanan M, Stieger B, Meier PJ, Suchy FJ, Anwer MS Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate. Hepatology 1998, 28:1629-1636.
170. +/taurocholate cotransport. J Biol Chem 1998, 273:30039-30045.
171. Dranoff JA, McClure M, Burgstahler AD, Denson LA, Crawford AR, Crawford JM, et al. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology 1999, 30:223-229.
172. Webster CRL, Blanch C, Anwer MS Role of PP2B in cAMP-induced dephosphorylation and translocation of NTCP. Am J Physiol Gastrointest Liver Physiol 2002, 283:G44-G50.
173. Webster CRL, Anwer MS Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver ntcp. Am J Physiol 1999, 277:G1165-G1172.
174. Sarkar S, Bananis E, Nath S, Anwer MS, Murray JW, Wolkoff AW Vesicles containing ntcp are part of the recycling endosome pool and are enriched in dynein and myosin IIA. Hepatology 2004, 40:487A.
175. McConkey M, Gillin H, Webster CR, Anwer MS Cross-talk between protein kinases Czeta and B in cyclic AMP-mediated sodium taurocholate co-transporting polypeptide translocation in hepatocytes. J Biol Chem 2004, 279:20882-20888.
176. Sarkar S, Bananis E, Nath S, Anwer MS, Wolkoff AW, Murray JW PKCz is required for microtubule-based motility of vesicles containing the ntcp transporter. Traffic 2006, 7:1078-1091.
177. Murray JW, Sarkar S, Wolkoff AW Single vesicle analysis of endocytic fission on microtubules in vitro. Traffic 2008, 9:833-847.
178. Murray JW, Wolkoff AW Assay of Rab4-dependent trafficking on microtubules. Methods Enzymol 2005, 403:92-107.
179. +/taurocholate cotransport and Ntcp translocation. J Biol Chem 2002, 277:28578-28583.
180. Brock WJ, Vore M Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes. J Pharmacol Exp Ther 1984, 229:175-181.
181. +/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol 2003, 38:148-155.
182. Simon FR, Fortune J, Iwahashi M, Qadri I, Sutherland E Multihormonal regulation of hepatic sinusoidal Ntcp gene expression. Am J Physiol Gastrointest Liver Physiol 2004, 287:G782-G794.
183. Brock WJ, Vore M The effect of pregnancy and treatment with 17 beta-estradiol on the transport of organic anions into isolated rat hepatocytes. Drug Metab Dispos 1984, 12:713-716.
184. +/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats. J Pharmacol Exp Ther 1993, 267:82-87.
185. +/taurocholate co-transport activity and messenger RNA post partum. Biochem J 1994, 303:33-36.
186. +-TC cotransport. Am J Physiol 1995, 268:G11-G17.
187. Wagner M, Zollner G, Trauner M Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin Liver Dis 2010, 30:160-177.
188. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000, 118:163-172.
189. Lee J, Boyer JL Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000, 20:373-384.
190. Cleland DP, Bartholomew TC, Billing BH Hepatic transport of sulfated and nonsulfated bile acids in the rat following relief of bile duct obstruction. Hepatology 1984, 4:477-485.
191. Fricker G, Landmann L, Meier PJ Extrahepatic obstructive cholestasis reverses the bile salt secretory polarity of rat hepatocytes. J Clin Invest 1989, 84:876-885.
192. Baumgartner U, Scholmerich J, Weitzel C, Ihling C, Sellinger M, Lohle E, et al. Pattern of bile acid regurgitation and metabolism during perfusion of the bile duct obstructed rat liver. J Hepatol 1995, 22:208-218.
193. Teng S, Piquette-Miller M Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 2007, 151:367-376.
194. Dawson PA, Lan T, Rao A Bile acid transporters. J Lipid Res 2009, 50:2340-2357.
195. Stieger B, Meier Y, Meier PJ The bile salt export pump. Pflugers Arch 2007, 453:611-620.
196. Nies AT, Keppler D The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 2007, 453:643-659.
197. Jansen PLM, Muller M, Sturm E Genes and cholestasis. Hepatology 2001, 34:1067-1074.
198. +-independent transport system. J Clin Invest 1984, 73:659-663.
199. Inoue M, Akerboom TPM, Sies H, Kinne R, Thao T, Arias IM Biliary transport of glutathione S-conjugate by rat liver canalicular membrane vesicles. J Biol Chem 1984, 259:4998-5002.
200. Nishida T, Gatmaitan Z, Che M, Arias IM Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sci USA 1991, 88:6590-6594.
201. Muller M, Ishikawa T, Berger U, Klunemann C, Lucka L, Schreyer A, et al. ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem 1991, 266:18920-18926.
202. Adachi Y, Kobayashi H, Kurumi Y, Shouji M, Kitano M, Yamamoto T ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 1991, 14:655-659.
203. Stieger B, O'Neill B, Meier PJ ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles. Biochem J 1992, 284:67-74.
204. Ruetz S, Hugentobler G, Meier PJ Functional reconstitution of the canalicular bile salt transport system of rat liver. Proc Natl Acad Sci USA 1988, 85:6147-6151.
205. Becker A, Lucka L, Kilian C, Kannicht C, Reutter W Characterization of the ATP-dependent taurocholate-carrier protein (gp110) of the hepatocyte canalicular membrane. Eur J Biochem 1993, 214:539-548.
206. Lin SH Localization of the ecto-ATPase (ecto-nucleotidase) in the rat hepatocyte plasma membrane. Implications for the functions of the ecto-ATPase. J Biol Chem 1989, 264:14403-14407.
207. Lin SH, Guidotti G Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein. J Biol Chem 1989, 264:14408-14414.
208. Sippel CJ, Suchy FJ, Ananthanarayanan M, Perlmutter DH The rat liver ecto-ATPase is also a canalicular bile acid transport protein. J Biol Chem 1993, 268:2083-2091.
209. Kast C, Stieger B, Winterhalter KH, Meier PJ Hepatocellular transport of bile acids. Evidence for distinct subcellular localizations of electrogenic and ATP-dependent taurocholate transport in rat hepatocytes. J Biol Chem 1994, 269:5179-5186.
210. Luther TT, Hammerman P, Rahmaoui CM, Lee PP, Sela-Herman S, Matula GS, et al. Evidence for an ATP-dependent bile acid transport protein other than the canalicular liver ecto-ATPase in rats. Gastroenterology 1997, 113:249-254.
211. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998, 273:10046-10050.
212. Jansen PLM, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJEJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999, 117:1370-1379.
213. Lam P, Soroka CJ, Boyer JL The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease. Semin Liver Dis 2010, 30:125-133.
214. Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 2001, 98:2011-2016.
215. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ Drug and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (bsep) of rat liver. Gastroenterology 2000, 118:422-430.
216. Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology 2002, 123:1649-1658.
217. Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther 2005, 314:876-882.
218. Paulusma CC, Elferink RP, Jansen PL Progressive familial intrahepatic cholestasis type 1. Semin Liver Dis 2010, 30:117-124.
219. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis 2010, 30:134-146.
220. Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010, 51:1645-1655.
221. Alissa FT, Jaffe R, Shneider BL Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2008, 46:241-252.
222. Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998, 18:219-224.
223. Eppens EF, van Mil SW, de Vree JM, Mok KS, Juijn JA, Oude Elferink RP, et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 2001, 35:436-443.
224. Harris MJ, Kagawa T, Dawson PA, Arias IM Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells. J Gastroenterol Hepatol 2004, 19:819-825.
225. Paulusma CC, Groen A, Kunne C, Ho-Mok KS, Spijkerboer AL, Rudi dW, et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006, 44:195-204.
226. Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 2009, 136:1060-1069.
227. DeVree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998, 95:282-287.
228. Ruetz S, Gros P Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994, 77:1071-1081.
229. Morita SY, Kobayashi A, Takanezawa Y, Kioka N, Handa T, Arai H, et al. Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4. Hepatology 2007, 46:188-199.
230. Jacquemin E Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin Liver Dis 2001, 21:551-562.
231. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993, 75:451-462.
232. Wolkoff AW The hyperbilirubinemias. Harrison's Principles of Internal Medicine 2010, 1927-1931. McGraw Hill, New York. 17th ed. A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson, J. Loscalzo (Eds.).
233. Nishida T, Gatmaitan Z, Roy-Chowdhry J, Arias IM Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. J Clin Invest 1992, 90:2130-2135.
234. Kitamura T, Jansen P, Hardenbrook C, Kamimoto Y, Gatmaitan Z, Arias IM Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci USA 1990, 87:3557-3561.
235. Nishida T, Hardenbrook C, Gatmaitan Z, Arias IM ATP-dependent organic anion transport system in normal and TR-rat liver canalicular membranes. Am J Physiol 1992, 262:G629-G635.
236. Jansen PL, Peters WH, Lamers WH Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985, 5:573-579.
237. Wolkoff AW, Cohen LE, Arias IM Inheritance of the Dubin-Johnson syndrome. N Engl J Med 1973, 288:113-117.
238. Mayer R, Kartenbeck J, Buchler M, Jedlitschky G, Leier I, Keppler D Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol 1995, 131:137-150.
239. Kartenbeck J, Leuschner U, Mayer R, Keppler D Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996, 23:1061-1066.
240. Keitel V, Nies AT, Brom M, Hummel-Eisenbeiss J, Spring H, Keppler D A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003, 284:G165-G174.
241. Keppler D, Konig J Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 1997, 11:509-516.
242. Jansen PLM, Van Klinken JW, Van Gelder M, Ottenhoff R, Oude Elferink RPJ Preserved organic anion transport in mutant TR-rats with a hepatobiliary secretion defect. Am J Physiol 1993, 265:G445-G452.
243. Kikuchi S, Hata M, Fukumoto K, Yamane Y, Matsui T, Tamura A, et al. Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Genet 2002, 31:320-325.
244. Nies AT, Konig J, Cui Y, Brom M, Spring H, Keppler D Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). Eur J Biochem 2002, 269:1866-1876.
245. Hung AY, Sheng M PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002, 277:5699-5702.
246. Akita H, Suzuki H, Ito K, Kinoshita S, Sato N, Takikawa H, et al. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump. Biochim Biophys Acta 2001, 1511:7-16.
247. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 2000, 275:2905-2910.
248. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol 1998, 53:1068-1075.
249. Akita H, Suzuki H, Sugiyama Y Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver. Pharm Res 2001, 18:1119-1125.
250. Konig J, Rost D, Cui Y, Keppler D Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999, 29:1156-1163.
251. Soroka CJ, Lee JM, Azzaroli F, Boyer JL Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001, 33:783-791.
252. Donner MG, Keppler D Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001, 34:351-359.
253. Scheffer GL, Kool M, de Haas M, de Vree JM, Pijnenborg AC, Bosman DK, et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 2002, 82:193-201.
254. Donner MG, Warskulat U, Saha N, Haussinger D Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 2004, 385:331-339.
255. Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 2004, 40:585-591.
256. Rebbeor JF, Connolly GC, Henson JH, Boyer JL, Ballatori N ATP-dependent GSH and glutathione S-conjugate transport in skate liver: role of an Mrp functional homologue. Am J Physiol Gastrointest Liver Physiol 2000, 279:G417-G425.
257. Cai SY, Soroka CJ, Ballatori N, Boyer JL Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate. Am J Physiol Regul Integr Comp Physiol 2003, 284:R125-R130.
258. Ballatori N, Rebbeor JF, Connolly GC, Seward DJ, Lenth BE, Henson JH, et al. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump. Am J Physiol Gastrointest Liver Physiol 2000, 278:G57-G63.
259. Cai SY, Wang L, Ballatori N, Boyer JL Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations. Am J Physiol Gastrointest Liver Physiol 2001, 281:G316-G322.
260. Vos TA, Ros JE, Havinga R, Moshage H, Kuipers F, Jansen PLM, et al. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 1999, 29:1833-1839.
261. Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, Suchy FJ Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr Res 2003, 53:288-294.
262. de Zwart L, Scholten M, Monbaliu JG, Annaert PP, Van Houdt JM, Van dW I, et al. The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 2008, 26:220-230.
263. Zinchuk VS, Okada T, Akimaru K, Seguchi H Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Physiol Gastrointest Liver Physiol 2002, 282:G540-G548.
264. Barth A, Fleck C, Klinger W Development of organic anion transport in the liver. Exp Toxic Pathol 1996, 48:421-432.
265. Hwang SW, Dixon RL Perinatal development of indocyanine green biliary excretion in guinea pigs. Am J Physiol 1973, 225:1454-1459.
266. Arrese M, Ananthananarayanan M, Suchy FJ Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998, 44:141-147.
267. Chen HL, Chen HL, Liu YJ, Feng CH, Wu CY, Shyu MK, et al. Developmental expression of canalicular transporter genes in human liver. J Hepatol 2005, 43:472-477.
268. 14C]phenytoin in the rat. J Pharmacol Exp Ther 1979, 208:257-262.
269. Muraca M, Leyten R, Fevery J Conjugation and maximal biliary excretion of bilirubin in the rat during pregnancy and lactation and during estroprogestogen treatment. Hepatology 1984, 4:633-638.
270. Durham S, Mack R, Vore M Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy. Drug Metab Dispos 1985, 13:695-699.
271. Trauner M, Meier PJ, Boyer JL Molecular pathogenesis of cholestasis. N Engl J Med 1998, 339:1217-1227.
272. Moseley RH, Wang W, Takeda H, Lown K, Shick L, Ananthanarayanan M, et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996, 271:G137-G146.
273. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997, 112:214-225.
274. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PL, Elferink RP Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995, 269:G427-G434.
275. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998, 28:1637-1644.
276. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997, 113:255-264.
277. Kipp H, Arias IM Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin Liver Dis 2000, 20:339-351.
278. Kipp H, Arias IM Trafficking of canalicular ABC transporters in hepatocytes. Annu Rev Physiol 2002, 64:595-608.
279. Wakabayashi Y, Kipp H, Arias IM Transporters on demand: intracellular reservoirs and cycling of bile canalicular ABC transporters. J Biol Chem 2006, 281:27669-27673.
280. Hayakawa T, Bruck R, Ng OC, Boyer JL DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am J Physiol 1990, 259:G727-G735.
281. Hayakawa T, Ng OC, Ma A, Boyer JL, Cheng O Taurocholate stimulates transcytotic vesicular pathways labeled by horseradish peroxidase in the isolated perfused rat liver. Gastroenterology 1990, 99:216-228.
282. Gatmaitan ZC, Nies AT, Arias IM Regulation and translocation of ATP-dependent apical membrane proteins in rat liver. Am J Physiol 1997, 272:G1041-G1049.
283. Misra S, Gatmaitan Z, Varticovski L, Arias IM The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem 1998, 273:26638-26644.
284. Kipp H, Pichetshote N, Arias IM Transporters on demand: intrahepatic pools of canalicular ATP binding cassette transporters in rat liver. J Biol Chem 2001, 276:7218-7224.
285. Tuma PL, Finnegan CM, Yi JH, Hubbard AL Evidence for apical endocytosis in polarized hepatic cells: phosphoinositide 3-kinase inhibitors lead to the lysosomal accumulation of resident apical plasma membrane proteins. J Cell Biol 1999, 145:1089-1102.
286. Ihrke G, Martin GV, Shanks MR, Schrader M, Schroer TA, Hubbard AL Apical plasma membrane proteins and endolyn-78 travel through a subapical compartment in polarized WIF-B hepatocytes. J Cell Biol 1998, 141:115-133.
287. Wakabayashi Y, Lippincott-Schwartz J, Arias IM Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes. Mol Biol Cell 2004, 15:3485-3496.
288. Schafer DA Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol 2002, 14:76-81.
289. Ortiz DF, Moseley J, Calderon G, Swift AL, Li S, Arias IM Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells. J Biol Chem 2004, 279:32761-32770.
290. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999, 284:1365-1368.
291. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999, 284:1362-1365.
292. Wang H, Chen J, Hollister K, Sowers LC, Forman BM Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999, 3:543-553.
293. Goodwin B, Kliewer SA Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 2002, 282:G926-G931.
294. Xie W, Evans RM Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 2001, 276:37739-37742.
295. Karpen SJ Nuclear receptor regulation of hepatic function. J Hepatol 2002, 36:832-850.
296. Edwards PA, Kast HR, Anisfeld AM BAREing it all. The adoption of lxr and fxr and their roles in lipid homeostasis. J Lipid Res 2002, 43:2-12.
297. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002, 277:2908-2915.
298. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 2001, 276:28857-28865.
299. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000, 6:517-526.
300. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000, 6:507-515.
301. Zhang M, Chiang JY Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem 2001, 276:41690-41699.
302. Castillo-Olivares A, Gil G Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. Nucleic Acids Res 2001, 29:4035-4042.
303. Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001, 121:140-147.
304. Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, et al. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 2003, 278:41930-41937.
305. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998, 92:73-82.
306. Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB, Kliewer SA, et al. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 2003, 278:45062-45071.
307. Krebs JS, Brauer RW Metabolism of sulfobromophthalein sodium (BSP) in the rat. Am J Physiol 1958, I94:37-43.
308. Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 2003, 100:223-228.
309. Goodwin B, Redinbo MR, Kliewer SA Regulation of cyp3a gene transcription by the pregnane x receptor. Annu Rev Pharmacol Toxicol 2002, 42:1-23.
310. Teng S, Piquette-Miller M The involvement of PXR in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 2004.
311. Tirona RG, Leake BF, Podust LM, Kim RB Identification of amino acids in rat pregnane X receptor that determine species-specific activation. Mol Pharmacol 2004, 65:36-44.
312. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis. J Clin Invest 2003, 112:1678-1687.
313. Claudel T, Sturm E, Kuipers F, Staels B The farnesoid X receptor: a novel drug target?. Expert Opin Investig Drugs 2004, 13:1135-1148.